A Medical Officer’s Approach to NDA/BLA Review (8of15) REdI Annual Conference - May 29-30, 2019

  Рет қаралды 2,574

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
Regulatory Highlights for Biosimilars and Interchangeables (9of15) REdI - May 29-30, 2019
42:43
U.S. Food and Drug Administration
Рет қаралды 4,9 М.
NDA and BLA Application Review Process (6of15) REdI Annual Conference - May 29-30, 2019
38:21
U.S. Food and Drug Administration
Рет қаралды 15 М.
She made herself an ear of corn from his marmalade candies🌽🌽🌽
00:38
Valja & Maxim Family
Рет қаралды 18 МЛН
Support each other🤝
00:31
ISSEI / いっせい
Рет қаралды 81 МЛН
Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017
46:00
U.S. Food and Drug Administration
Рет қаралды 21 М.
Formal Meetings for PDUFA Products and Communication Best Practices (4of14) REdI 2018
39:14
U.S. Food and Drug Administration
Рет қаралды 3 М.
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
1:20:20
FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session One
2:14:51
U.S. Food and Drug Administration
Рет қаралды 1 М.
FDA Clinical Investigator Training Course (CITC) 2024 - Day Two - Session Two
2:23:52
U.S. Food and Drug Administration
Рет қаралды 654
FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session Two
1:42:25
U.S. Food and Drug Administration
Рет қаралды 1,9 М.
FDA Clinical Investigator Training Course (CITC) 2024 - Day Two - Session One
1:51:03
U.S. Food and Drug Administration
Рет қаралды 686
FDA Clinical Investigator Training Course (CITC) 2024 - Day Three - Session One
1:43:17
U.S. Food and Drug Administration
Рет қаралды 445
National Drug Code (NDC) for Healthcare Providers
41:59
U.S. Food and Drug Administration
Рет қаралды 1,2 М.
FDA Clinical Investigator Training Course (CITC) 2024 - Day Three - Session Two
1:47:20
U.S. Food and Drug Administration
Рет қаралды 808